In a preclinical study, matastasis associated lung adenocarcinoma transcript 1 (Malat1)-specific ASO along with nucleus-targeting peptide gold nanoparticles, reduced Malat1 expression and suppressed metastatic tumor nodule formation in vivo [121]. The gene discussed is MALAT1; the disease is neoplasm.